TCL Archive “Forward Funding” Will Cost NCI $38 Million, 270 Grants, As OMB Legally Impounds FY 1985 Money February 1, 1985
TCL Archive Aranesp Study Finds No Difference In Survival Or Progression In Small-Cell Lung Cancer. April 20, 2007
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004